GlassScriptPhysician profile
Brent J Michael
NPI 1275698052
$5,074.39
in general payments reported to CMS, 2019-2025
37 companies · $1,054 in 2025
The $1,054 reported for 2025 was more than what 87% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $294 · 2020: $420 · 2021: $835 · 2022: $548 · 2023: $1,018 · 2024: $905 · 2025: $1,054.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,977.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,976.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $902.60 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Amgen INC. | $758.85 | 2019-2025 | Otezla, Repatha, Evenity |
| Glaxosmithkline, LLC. | $734.34 | 2019-2025 | Trelegy Ellipta |
| Abbvie INC. | $634.32 | 2021-2025 | |
| Lilly USA, LLC | $299.55 | 2020-2025 | Mounjaro, Jardiance, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $271.29 | 2021-2025 | Jardiance, Tradjenta, Synjardy |
| Pfizer INC. | $178.76 | 2019-2024 | |
| Novartis Pharmaceuticals Corporation | $121.51 | 2023-2025 | |
| Allergan, INC. | $105.25 | 2019-2020 | |
| Eisai INC. | $94.12 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $86.04 | 2023-2024 | Xarelto |
| Novo Nordisk INC | $71.75 | 2021-2024 | Ozempic, Rybelsus |
| Idorsia Pharmaceuticals US INC | $67.66 | 2023-2024 | Quviviq |
| Ani Pharmaceuticals, INC. | $67.40 | 2025 | Purified Cortrophin Gel |
| Scilex Pharmaceuticals INC. | $62.73 | 2023-2025 | Ztlido |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brent Michael listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.